Florian Battung,Pierre-Yves Juvin,Jérôme Hecq,Aude Colin
申请号:
US14441054
公开号:
US20150258118A1
申请日:
2013.11.07
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The subject of the present invention is a co-micronization product comprising: an active ingredient selected from the group consisting of selective progesterone receptor modulators, metabolites thereof and mixtures thereof, and an N-vinyl-2-pyrrolidone-based polymeric excipient. The invention also relates to a pharmaceutical composition comprising said co-micronization product and to the therapeutic uses thereof.